Miroslav Šašinka, Katarína Furková
Resolving of the inflammation is an active process stimulated by new endogenous lipid mediators lipoxins, resolvins and protectins. These mediators are synthesized from n-3-polyunsaturated fatty acids (eicosapentaenic and docohexaenic acid) and have intensive anti-inflammatory, healing and antifibrotic effects. The evidences on key role of the endogenous resolvins and protectins in the healing of the inflammation opened a way to the total new anti-inflammatory and healing therapy by stimulation of the endogenous healing mechanisms. This therapy has not unfavorable side effects of the COX-2 inhibitors or of the biologic therapy with anti-TNF drugs. Many laboratories work on the access of these new lipid mediators for routine management and some drugs are in clinical testing. We can therefore wait substantive revolution in the management of the inflammatory diseases which continually rank to the most important problems of the contemporary medicine.